Dengue virus non-structural protein 1: A pathogenic factor, therapeutic target, and vaccine candidate

Hong Ru Chen, Yen Chung Lai, Trai Ming Yeh

Research output: Contribution to journalReview articlepeer-review

87 Citations (Scopus)

Abstract

Dengue virus (DENV) infection is the most common mosquito-transmitted viral infection. DENV infection can cause mild dengue fever or severe dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Hemorrhage and vascular leakage are two characteristic symptoms of DHF/DSS. However, due to the limited understanding of dengue pathogenesis, no satisfactory therapies to treat nor vaccine to prevent dengue infection are available, and the mortality of DHF/DSS is still high. DENV nonstructural protein 1 (NS1), which can be secreted in patients' sera, has been used as an early diagnostic marker for dengue infection for many years. However, the roles of NS1 in dengue-induced vascular leakage were described only recently. In this article, the pathogenic roles of DENV NS1 in hemorrhage and vascular leakage are reviewed, and the possibility of using NS1 as a therapeutic target and vaccine candidate is discussed.

Original languageEnglish
Article number58
JournalJournal of biomedical science
Volume25
Issue number1
DOIs
Publication statusPublished - 2018 Jul 24

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Dengue virus non-structural protein 1: A pathogenic factor, therapeutic target, and vaccine candidate'. Together they form a unique fingerprint.

Cite this